Delving into the Latest Updates on Fujian Longhua Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Digestive System Disorders

Neoplasms

Chemical drugs

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Chemical drugs	1

Top 5 Target	Count

caspase 3(Caspase-3)	1

主要目的：评价福大赛因注射液对于改善食管阻塞和吞咽困难症状的疗效。次要目的：评价福大赛因注射液治疗前后肿瘤病灶缩小情况；评价福大赛因注射液治疗前后生活质量改善情况；评价福大赛因注射液治疗的安全性及潜在操作风险的控制。

[Translation]

Primary objective: To evaluate the efficacy of Fosdaigin injection in improving esophageal obstruction and dysphagia. Secondary objectives: To evaluate the reduction of tumor lesions before and after Fosdaigin injection treatment; to evaluate the improvement of quality of life before and after Fosdaigin injection treatment; to evaluate the safety of Fosdaigin injection treatment and the control of potential operational risks.

Start Date08 Oct 2016

Sponsor / Collaborator

Fuzhou University

[+1]

NCT01043016 / Unknown statusPhase 1

Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant Tumors

The purpose of this study is to determine the safety and maximum tolerated dose of Photocyanine injection in photodynamic therapy of malignant tumor (especially skin cancer and esophageal cancer).
Projected accrual: A total of 18-24 patients will be accrued for this study.

Start Date01 Mar 2009

Sponsor / Collaborator

Fujian Longhua Pharmaceutical Co., Ltd.

[+2]

100 Clinical Results associated with Fujian Longhua Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Fujian Longhua Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Fujian Longhua Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Fujian Longhua Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Login to view more data